Skip to main content
Atrás
Watch Compare

Anebulo Pharmaceuticals, Inc.

Calidad de datos: 83%
ANEB
OTC Manufacturing Chemicals
$0.54
▼ $0.04 (-6.90%)
Cap. Mercado: 24.51 M
Precio
$0.60
Cap. Mercado
24.51 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -5.84 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-90.29%
Below sector avg (-53.47%)
ROIC-71.48%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-28.84

Valoración

PE (TTM)
-3.07
Below sector avg (-1.48)
P/B Ratio3.09
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -3.1 -1.5
P/B 3.1 1.6
ROE % -90.3 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

1 analista
No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2026 — 0.0 —

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q32025 -$0.12 -$0.05 +58.3%
Q22025 -$0.05 -$0.05 0.0%
Q12025 -$0.05 -$0.04 +20.0%
Q42024 -$0.08 -$0.09 -12.5%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -7.98 M
ROE -90.29% ROA -79.30%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -5.84 M
ROIC -71.48% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage -28.84 Asset Turnover N/A
Working Capital N/A Tangible Book Value 7.94 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.07 Forward P/E N/A
P/B Ratio 3.09 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23.83%
Market Cap 24.51 M Enterprise Value 15.47 M
Per Share
EPS (Diluted TTM) -0.18 Revenue / Share N/A
FCF / Share -0.14 OCF / Share -0.14
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 73.20%
SBC-Adj. FCF -6.82 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue — — — — —
Net Income -8.48 M -8.20 M -11.73 M -30.25 M -6.83 M
EPS (Diluted) -0.25 -0.32 0.47 — —
Gross Profit — — — — —
Operating Income -9.22 M -8.31 M -11.78 M — -6.83 M
EBITDA — — — — —
R&D Expenses 4.30 M 3.55 M 5.60 M 2.27 M 2.96 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 400,000.0 151,230.0 — 11,767.0 11,767.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 12.15 M 4.07 M 11.67 M 21.65 M 15.58 M
Total Liabilities 487,688.0 260,583.0 1.07 M 241,633.0 512,531.0
Shareholders' Equity 11.66 M 3.81 M 10.60 M 21.41 M 15.07 M
Total Debt — — — — —
Cash & Equivalents 11.63 M 3.09 M — — —
Current Assets 11.96 M 3.51 M — — —
Current Liabilities — — — — —